Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2020-04-29 Earnings Release
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Wstępne wybrane szacunkowe skonsolidowane dane finansowe Grupy Kapitałowej Selvita S.A. za I kwartał 2020 roku - Content (PL)
Earnings Release Classification · 99% confidence The document text, written in Polish, announces the preliminary, estimated consolidated financial data for Selvita S.A. for the first quarter (I kwartał) of 2020, along with comparative figures for Q1 2019. It explicitly states that these are preliminary figures and that the final figures will be published on May 26, 2020, via a current report (raport bieżący). Since this is an announcement of preliminary results for a specific financial period (Q1), it aligns best with the Earnings Release (ER) category, which covers the initial announcement of periodical financial results (key highlights only). Although it mentions a future definitive report, the content provided here is the initial release of estimated results. Q1 2020
2020-04-29 Polish
Zawarcie przedwstępnej umowy nabycia nieruchomości - Content (PL)
Capital/Financing Update Classification · 95% confidence The document text, written in Polish, describes the execution of a preliminary sale agreement (przedwstępna umowa sprzedaży) by Selvita S.A. to acquire a property (Nieruchomość) for 10,000,000 PLN. The acquisition is contingent upon shareholder approval (zgody Walnego Zgromadzenia Spółki). This transaction involves a significant asset purchase and a capital structure implication (future use of funds/asset base). While it relates to financing/capital structure, the core event is the agreement to acquire a major asset, which often falls under Capital/Financing Update (CAP) or sometimes Regulatory Filings (RNS) if no better fit exists. Since this is a definitive announcement about a major transaction (acquisition of land for a new facility) that requires shareholder approval, it strongly aligns with the 'Capital/Financing Update' category, as it concerns a major capital expenditure/asset acquisition plan. It is not an earnings release, audit report, or management change. Given the nature of the transaction (major asset acquisition requiring shareholder vote), CAP is the most appropriate fit.
2020-04-29 Polish
Otrzymanie dofinansowania dla projektu Emitenta od NCBiR - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from the Management Board ('Zarząd') of Selvita S.A. regarding the signing of an agreement with the National Centre for Research and Development (NCBiR) to receive funding (dofinansowanie) for a research project (HiScAI). This announcement details the nature of the project (drug discovery platform using AI), the total value, the amount of funding secured (4.8 million PLN), and the duration (three years). This type of announcement, concerning securing financing or grants for strategic projects, aligns best with the 'Capital/Financing Update' category, as it directly relates to the company's funding activities and capital structure enhancement through external grants. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA), but a specific announcement about securing capital/funding for development.
2020-04-24 Polish
Rozszerzenie współpracy w ramach umowy znaczącej - Content (PL)
Capital/Financing Update Classification · 92% confidence The document text is very short (851 characters) and announces a significant event: the expansion of an existing cooperation agreement with a client, detailing the new total value of the contract (624,984 EUR / 1,142,300 EUR total). This relates to fundraising, financing activities, or material contract changes that impact the company's financial outlook or structure. It is not a full report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it details a material contract amendment and its financial impact, it best fits the 'Capital/Financing Update' category, as major contract wins/expansions often fall under this umbrella when they significantly alter revenue expectations, or potentially 'Regulatory Filings' (RNS) if it were a general announcement. Given the specific nature of announcing a material contract value increase, 'CAP' (Capital/Financing Update) is the most appropriate specific classification, although 'RNS' is a close fallback if 'CAP' is interpreted strictly as debt/equity financing. However, significant contract value changes are often grouped with financing events. I will classify it as CAP due to the material financial impact described.
2020-03-31 Polish
Pismo Prezesa Zarządu Selvita S.A. - List do akcjonariuszy
Management Reports Classification · 95% confidence The document is a letter from the CEO of Selvita S.A. addressed to shareholders, reviewing the company's performance in 2019, discussing the corporate split, financial results, and future strategy. It functions as a management commentary or review of the year, which is characteristic of the 'Management Reports' (MDA) category. It is not a full Annual Report (10-K) as it lacks the comprehensive financial statements and audit disclosures, nor is it a simple announcement (RPA) as it provides substantive narrative analysis of business trends and outlook. FY 2019
2020-03-26 Polish
Oświadczenie Rady Nadzorczej Selvita S.A. dot. działania komitetu audytu oraz firmy audytorskiej
Audit Report / Information Classification · 95% confidence The document is titled "Oświadczenie Rady Nadzorczej Selvita S.A. dotyczące funkcjonowania Komitetu Audytu oraz firmy audytorskiej" (Statement of the Supervisory Board of Selvita S.A. regarding the functioning of the Audit Committee and the audit firm). It explicitly references compliance with regulations concerning the audit committee, the audit firm (Ernst & Young), and the audit of the annual financial statements for 2019. This content directly relates to the formal audit process and the oversight thereof, which aligns best with the 'Audit Report / Information' category, as it is a formal statement about the audit function, distinct from the full Annual Report (10-K) or a general Earnings Release (ER). FY 2019
2020-03-26 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.